Tattoo-associated complications of metastatic melanoma treated with dabrafenib and trametinib

Melanoma Res. 2018 Oct;28(5):485-487. doi: 10.1097/CMR.0000000000000486.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Female
  • Humans
  • Imidazoles / pharmacology
  • Imidazoles / therapeutic use*
  • Melanoma / complications*
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Oximes / pharmacology
  • Oximes / therapeutic use*
  • Pyridones / pharmacology
  • Pyridones / therapeutic use*
  • Pyrimidinones / pharmacology
  • Pyrimidinones / therapeutic use*
  • Tattooing / adverse effects*

Substances

  • Imidazoles
  • Oximes
  • Pyridones
  • Pyrimidinones
  • trametinib
  • dabrafenib